New study quantifies total costs of fragility fractures in six major European countries

New research estimates that the economic burden of fragility fractures in five major European countries totals 31 billion Euro, with Germany bearing the highest costs. A majority of the economic burden is shown to be related to the costs incurred during the first year after the fracture, while pharmacological prevention and treatment management constitutes only a marginal share of the total economic cost.

Molecular Biology Genetics Genes Biology